(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

USO DE UM AGENTE TERAPÊUTICO QUE INIBE A POLI [ADPRIBOSE] POLIMERASE ("TERAPIA ANTI-PARP") E AGENTE TERAPÊUTICO QUE INIBE A POLI [ADP-RIBOSE] POLIMERASE ("TERAPIA ANTI-PARP")

IndeferidaInvention PatentPCT · US2017040039

Application data

Number

112018077492

Type

Invention Patent

Filing

06/29/2017

Publication

04/09/2019

PCT

US2017040039

Progress at the INPI

Under appeal
  1. Filing06/29/17
  2. Publication04/09/19
  3. Examination
  4. Refused04/08/25
  5. Grant
  6. In force

The application was refused by the INPI on 04/08/2025. The invention was never patented.

Talk to a specialist

Latest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TESARO, INC.

US

See this company's full portfolio

Inventors

M. H. (pessoa física)

US

R. M. (pessoa física)

US

Technical data

Priority claims

US

62/356,461 · 06/29/2016

US

62/402,427 · 09/30/2016

US

62/470,141 · 03/10/2017

Abstract

A presente invenção fornece métodos de administração de um inibidor de PARP a um paciente com câncer.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Indeferimento

#9.2

04/08/2025

RPI 2831

15.50

O pedido foi dividido no BR122024025043-8 protocolo 870240102059 em 29/11/2024 15:20.

02/04/2025

RPI 2822

Conhecimento de parecer técnico

#7.1

12/10/2024

RPI 2814

Conhecimento de parecer técnico

#7.1

08/27/2024

RPI 2799

Conhecimento de parecer técnico

#7.1

05/07/2024

RPI 2783

Parecer de pré-exame

#6.23

10/13/2021

RPI 2649

Adição na publicação

#15.35

09/21/2021

RPI 2646

Notificação de entrada na fase nacional - PCT

#1.3

04/09/2019

RPI 2518

Alteração de dados cadastrais

#1.1

01/08/2019

RPI 2505

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.